Literature DB >> 7496704

Computed tomography manifestations of tricuspid regurgitation.

M A Collins1, J W Pidgeon, R Fitzgerald.   

Abstract

Six patients undergoing dynamic contrast enhanced abdominal computed tomography (CT) for upper abdominal symptoms and signs are described. Each patient demonstrated early, intense opacification of the inferior vena cava (IVC) and hepatic veins, exceeding that in the aorta on scans through the upper abdomen. Opacification of the IVC returned to normal on more caudal slices. All six patients were found to have echocardiographically proven tricuspid regurgitation (TR). It is suggested that this sign occurs in patients with TR due to direct reflux of contrast from the right atrium into the IVC during protracted bolus injection. Additional CT findings included patchy parenchymal liver enhancement in four patients and ascites in five. Recognition of this simple sign may direct the clinician to a cardiac aetiology for upper abdominal symptoms and signs.

Entities:  

Mesh:

Year:  1995        PMID: 7496704     DOI: 10.1259/0007-1285-68-814-1058

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

1.  A step toward hemodynamic assessment with CT angiography.

Authors:  Daniel W Groves; Andrew J Einstein
Journal:  J Cardiovasc Comput Tomogr       Date:  2011-01-20

2.  Cardiac tamponade: contrast reflux as an indicator of cardiac chamber equalization.

Authors:  Foeke Jacob Harmen Nauta; Wernard Aat Antoine Borstlap; Michael Stella; Zain Khalpey
Journal:  J Cardiothorac Surg       Date:  2012-05-31       Impact factor: 1.637

3.  Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension.

Authors:  Andrew J Swift; Krit Dwivedi; Chris Johns; Pankaj Garg; Matthew Chin; Ben J Currie; Alex Mk Rothman; Dave Capener; Yousef Shahin; Charlie A Elliot; Thanos Charalampopolous; Ian Sabroe; Smitha Rajaram; Catherine Hill; Jim M Wild; Robin Condliffe; David G Kiely
Journal:  Eur Radiol       Date:  2020-04-27       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.